STIF

Daniel Arias

Q: How accurate are Daniel Arias's stock ratings?

About 67% of Daniel's ratings were profitable over a one-year hold, with an average return of +11.9% per rating, measured by 13Foresight from historical prices.

Q: How is Daniel ranked?

Daniel Arias is ranked #175 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Stifel Nicolaus

Wall Street Analyst

★★★★★

#175

on 13Foresight · ranked by our own returns

67%

Success Rate

+11.9%

Average Return

33 of 49 calls profitable · +8.9% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

🔒 3-year track record is Pro. Showing 1-year — upgrade.

📈 Across the calls we could measure, roughly 67% of Daniel Arias's ratings turned a profit when each position was held for 1 year — averaging +11.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

71 Buy 34 Hold 0 Sell

Daniel's Stock Coverage 24 ratings · 2026-08-13

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
MASS 908 Devices	Aug 12, 2026	BUY	Strong Buy +20.0% avg upside 4 analysts	$12.00 19.85% Upside	+0.0%	·
ALMR Alamar Biosciences, Inc.	Aug 11, 2026	BUY	Strong Buy +0.2% avg upside 5 analysts	$32.00 3.29% Downside	·	·
MRVI Maravai Lifesciences Holdings	Aug 11, 2026	BUY	Strong Buy +148.3% avg upside 17 analysts	$8.00 38.44% Upside	+0.0%	·
TXG 10x Genomics	Aug 11, 2026	BUY	Buy -28.8% avg upside 18 analysts	$50.00 13.48% Downside	+0.3%	·
QGEN Qiagen	Aug 11, 2026	HOLD	Buy -0.1% avg upside 24 analysts	$40.00 6.92% Downside	·	·
RPID Rapid Micro Biosystems	Aug 10, 2026	BUY	Strong Buy +417.1% avg upside 6 analysts	$8.00 373.31% Upside	-1.2%	·
BLLN BillionToOne, Inc. Class A	Aug 06, 2026	BUY	Strong Buy +25.6% avg upside 9 analysts	$145.00 48.74% Upside	+2.6%	·
RVTY Revvity	Aug 05, 2026	HOLD	Buy -7.8% avg upside 23 analysts	$110.00 6.63% Downside	+2.5%	·
WAT Waters	Aug 05, 2026	HOLD	Strong Buy -5.3% avg upside 31 analysts	$420.00 0.84% Upside	+3.1%	·
TMO Thermo Fisher	Aug 05, 2026	BUY	Strong Buy +0.4% avg upside 38 analysts	$650.00 7.75% Upside	+3.8%	·
BRKR Bruker	Aug 05, 2026	HOLD	Buy -2.3% avg upside 22 analysts	$50.00 15.66% Downside	+10.9%	·
ILMN Illumina	Aug 04, 2026	BUY	Buy -8.8% avg upside 31 analysts	$225.00 16.65% Upside	-5.1%	·
TEM Tempus AI, Inc. Class A	Aug 03, 2026	HOLD	Buy +19.4% avg upside 21 analysts	$50.00 8.52% Downside	+17.9%	·
GH Guardant Health	Aug 03, 2026	BUY	Strong Buy -0.7% avg upside 31 analysts	$180.00 9.08% Upside	+0.4%	·
MTD Mettler-Toledo	Aug 03, 2026	BUY	Buy -15.6% avg upside 18 analysts	$1600.00 11.20% Upside	-0.4%	·
AVTR Avantor	Jul 30, 2026	HOLD	Buy +11.3% avg upside 26 analysts	$15.00 7.68% Upside	-0.1%	·
RGEN Repligen	Jul 29, 2026	BUY	Strong Buy +4.7% avg upside 25 analysts	$207.00 24.96% Upside	+17.6%	·
DHR Danaher	Jul 22, 2026	BUY	Strong Buy +2.4% avg upside 45 analysts	$220.00 6.92% Upside	+14.2%	·
MXCT MaxCyte	Jul 22, 2026	BUY	Buy +214.9% avg upside 5 analysts	$4.00 214.88% Upside	+21.9%	·
A Agilent	May 28, 2026	BUY	Strong Buy +0.4% avg upside 33 analysts	$170.00 14.61% Upside	+10.5%	·
TECH Bio-Techne	May 07, 2026	HOLD	Buy +15.5% avg upside 21 analysts	$50.00 30.82% Downside	+42.1%	·
CDXS Codexis	Nov 10, 2025	BUY	Strong Buy +566.4% avg upside 13 analysts	$5.00 212.46% Upside	-13.7%	·
ABSI AbSci	Jan 22, 2025	HOLD	Strong Buy +28.1% avg upside 18 analysts	—	-21.6%	·
RNLXY Renalytix	Mar 01, 2024	BUY	Strong Buy +283.4% avg upside 5 analysts	$5.00 78.29% Upside	·	·

🔒 19 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Daniel Arias — Frequently Asked Questions

How accurate are Daniel Arias's stock ratings?

Based on the calls 13Foresight could measure, about 67% of Daniel's ratings were profitable over a one-year hold, with an average return of +11.9% per rating, or +8.9% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Daniel ranked on 13Foresight?

Daniel Arias is currently ranked #175 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Daniel cover?

Daniel most recently has ratings on MASS, ALMR, MRVI, TXG, QGEN, RPID, BLLN, RVTY, WAT, TMO, BRKR, ILMN and 12 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Daniel Arias

Rating Distribution

Welcome to 13Foresight!